Viewing by:
In the eight years since launching X-Therma, we’ve achieved chemistry breakthroughs that we believe will truly propel the field of organ transplant to a new
Cryopreservation has become a crucial component in realizing the large-scale commercial manufacturing of regenerative medicines, which require unique storage and transport strategies to ensure their
X-Therma posts our FCOI to meet requirements of our incoming NIH funding. You can read the policy here: XT_FCOI
Listen in on this discussion about the latest developments in cryopreservation technologies and how they can revolutionize cell and gene therapy manufacturing, processing, and their
In the past few years, specifically through the COVID-19 pandemic, supply-chain vulnerabilities have become the topic of everyday conversation across all industries— not just among
The world has been waiting for the next scientific breakthrough incryopreservation. Dimethyl sulfoxide (DMSO), a by-product of the wood industry, has been in usesince 1953.
The world has been waiting for the next scientific breakthrough in cryopreservation. Dimethyl sulfoxide (DMSO), a by-product of the wood industry, has been in use
X-Therma is proud to announce an important milestone on our journey toward enabling more and better organ transplants and off-the-shelf regenerative medicine therapies: Our company
The cryopreservation of hematopoietic cells using dimethyl sulfoxide (DMSO) and serum is a common procedure used in transplantation. However, DMSO has clinical and biological side effects due to its toxicity, and serum introduces variation and safety risks. Explore the development of a novel class of ice-interactive cryoprotectants inspired by natural antifreeze proteins.
I have spent my life thinking about time. How to pause it. How to create more of it. How to extend it, so that people
625 Alfred Nobel Drive
Suite B
Hercules, CA 94547
USA
X-Therma GmbH
Langer Weg 11
6020 Innsbruck
Austria
